A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants
Clinical trial NCT06655870 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06655870
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-06-23
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.